Calcium channel modulation as a target in chronic pain control
R Patel, C Montagut‐Bordas… - British Journal of …, 2018 - Wiley Online Library
Neuropathic pain remains poorly treated for large numbers of patients, and little progress
has been made in developing novel classes of analgesics. To redress this issue, ziconotide …
has been made in developing novel classes of analgesics. To redress this issue, ziconotide …
Calcium channel modulation as a target in chronic pain control
RA Patel, C Montagut Bordas… - British Journal of …, 2017 - discovery.ucl.ac.uk
Neuropathic pain remains poorly treated for large numbers of patients and little progress has
been made in developing novel classes of analgesics. To redress this issue, ziconotide …
been made in developing novel classes of analgesics. To redress this issue, ziconotide …
[PDF][PDF] Calcium channel modulation as a target in chronic pain control
R Patel, C Montagut-Bordas… - British Journal of …, 2017 - researchgate.net
Neuropathic syndromes are often characterized by a complex combination of positive and
negative sensory phenomena including allodynia (perceiving non-noxious stimuli as pain) …
negative sensory phenomena including allodynia (perceiving non-noxious stimuli as pain) …
[HTML][HTML] Calcium channel modulation as a target in chronic pain control
R Patel, C Montagut‐Bordas… - British Journal of …, 2018 - ncbi.nlm.nih.gov
Neuropathic pain remains poorly treated for large numbers of patients, and little progress
has been made in developing novel classes of analgesics. To redress this issue, ziconotide …
has been made in developing novel classes of analgesics. To redress this issue, ziconotide …
Calcium channel modulation as a target in chronic pain control
R Patel, C Montagut-Bordas… - British Journal of …, 2018 - kclpure.kcl.ac.uk
Neuropathic pain remains poorly treated for large numbers of patients, and little progress
has been made in developing novel classes of analgesics. To redress this issue, ziconotide …
has been made in developing novel classes of analgesics. To redress this issue, ziconotide …
Calcium channel modulation as a target in chronic pain control.
R Patel, C Montagut-Bordas… - British Journal of …, 2017 - europepmc.org
Neuropathic pain remains poorly treated for large numbers of patients, and little progress
has been made in developing novel classes of analgesics. To redress this issue, ziconotide …
has been made in developing novel classes of analgesics. To redress this issue, ziconotide …
Calcium channel modulation as a target in chronic pain control
R Patel, C Montagut-Bordas… - British journal of …, 2018 - pubmed.ncbi.nlm.nih.gov
Neuropathic pain remains poorly treated for large numbers of patients, and little progress
has been made in developing novel classes of analgesics. To redress this issue, ziconotide …
has been made in developing novel classes of analgesics. To redress this issue, ziconotide …
[PDF][PDF] Calcium channel modulation as a target in chronic pain control
R Patel, C Montagut-Bordas… - British Journal of …, 2018 - scienceopen.com
Neuropathic syndromes are often characterized by a complex combination of positive and
negative sensory phenomena including allodynia (perceiving non-noxious stimuli as pain) …
negative sensory phenomena including allodynia (perceiving non-noxious stimuli as pain) …
Calcium channel modulation as a target in chronic pain control.
R Patel, C Montagut-Bordas… - British Journal of …, 2017 - europepmc.org
Neuropathic pain remains poorly treated for large numbers of patients, and little progress
has been made in developing novel classes of analgesics. To redress this issue, ziconotide …
has been made in developing novel classes of analgesics. To redress this issue, ziconotide …